AstraZeneca
Bookmark
ShareAstraZeneca is a company. It is in Cambridge, the United Kingdom and it has a male CEO called Pascal Soriot. It was founded in 1999 and is part of the Health Care sector, specifically in the Pharmaceuticals industry.
Key facts
- city: Cambridge
- country: United Kingdom
- employees: 83,100 people
- revenues: 44B $
- sector: Health Care
- industry: Pharmaceuticals
- foundation year: 1999
- CEO: Pascal Soriot
- CEO gender: male
- CEO approval: 94 %
- ESG score: Try Pro to see estimate
- environmental score (ESG): Try Pro to see estimate
- social score (ESG): Try Pro to see estimate
- governance score (ESG): Try Pro to see estimate
See more facts
Extract data
Download datasets about AstraZeneca:
Dataset of stocks from AstraZeneca:
AstraZeneca is one of the companies in the United Kingdom, companies in Pharmaceuticals, companies in Health Care, companies in Pascal Soriot, companies in Cambridge and 3,456,835 companies in our database.
Talking Points
- AstraZenecaResearchBased BioPharmaceutical Company
- AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- We're transforming the future of healthcare by unlocking the power of what science can do. Community Guidelines: https://t.co/Kh08zUdFpT
- What science can do | AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation ...
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases. The company's marketed products also comprise Synagis for respiratory syncytial virus; Fluenz Tetra/FluMist Quadrivalent for Influenza; Seroquel IR/Seroquel XR for schizophrenia bipolar disease; Nexium, and Losec/Prilosec for gastroenterology; and Vaxzevria and Evusheld for covid-19. The company serves primary care and specialty care physicians through distributors and local representative offices in the United Kingdom, rest of Europe, the Americas, Asia, Africa, and Australasia. It has a collaboration agreement with Regeneron Pharmaceuticals, Inc. to research, develop, and commercialize small molecule medicines for obesity; Neurimmune AG to develop and commercialize NI006; Ionis Pharmaceuticals, Inc. to develop eplontersen, a liver-targeted antisense therapy in Phase III development for the treatment of transthyretin amyloidosis; Proteros Biostructures GmbH to jointly discover novel small molecules for the treatment of hematological cancers; Sierra Oncology, Inc. to develop and commercialize AZD5153. The company was formerly known as Zeneca Group PLC and changed its name to AstraZeneca PLC in April 1999. AstraZeneca PLC was incorporated in 1992 and is headquartered in Cambridge, the United Kingdom.
- Working at AstraZeneca
- Browse available job openings at Working at AstraZeneca
- We're driven by innovative science to deliver life-changing medicines to patients. Discover more about #LifeatAZ. Community Guidelines: https://t.co/JeGeUrfqtV
- Astra Zeneca LP Us is a Pharmaceuticals company located in 1800 Concord Pike, Wilmington, Delaware, United States.
